Searching for a crystal ball for prostate cancer treatment
NCT ID NCT06600802
Summary
This study aims to find molecular markers in a patient's original tumor tissue that can predict whether their advanced prostate cancer will respond to a targeted radiation treatment called Lu-PSMA. Researchers will analyze DNA and RNA from tumor samples of 120 men with metastatic, castration-resistant prostate cancer who are scheduled to receive Lu-PSMA. The goal is to identify biological signatures that can tell doctors in advance which patients are most likely to benefit from this treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CASTRATION-RESISTANT METASTATIC PROSTATE CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU de Grenoble
NOT_YET_RECRUITINGLa Tronche, 38700, France
Contact
-
Centre Jean PERRIN
RECRUITINGClermont-Ferrand, 63011, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Centre Paul STRAUSS
NOT_YET_RECRUITINGStrasbourg, 67091, France
Contact
-
Hospices Civiles de Lyon
NOT_YET_RECRUITINGPierre-Bénite, 69310, France
Contact
-
Hôpital privé de la Loire
NOT_YET_RECRUITINGSaint-Etienne, 42100, France
Contact
Conditions
Explore the condition pages connected to this study.